Investor Relations

SEC Filings

Document Details

Form
Filing Date
Jun 04, 2024
Document Date
Jun 04, 2024
Form Description
424B7    
Filing Group
Registration Statements
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.